Harold H. Shlevin, Chief Operating Officer at GALECTIN THERAPEUTICS INC (GALT), sold 74,616 shares at $6.50 ($565K) on 2018-06-12, disclosed to the SEC on 2018-06-14.
Open-market sale of $565k GALT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.50 | 12,780 | $83K | 14.7% |
| 2 | $7.79 | 30,918 | $241K | 42.6% |
| 3 | $7.79 | 30,918 | $241K | 42.6% |
| Total | $7.57 avg | 74,616 | $565K | 100% |
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |